To explore the effect of mutations harbored in different sites of TP53 and EGFR on metastases of NSCLC, we performed univariate analysis and marked the mutation site of the two genes of metastasis and none metastasis subgroups. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.